Middle-aged women with polycystic ovary syndrome (PCOS) exhibit only a moderately unfavourable cardiometabolic profile despite having an increased body mass index (BMI) and waist circumference, as reported in a study.
Big abdominal circumference in men may predict recurrence of cardiovascular events after a first myocardial infarction (MI) and this could well be a good prognosticator following acute coronary syndrome (ACS), a retrospective analysis has shown.
Individuals with new-onset prediabetes/diabetes after non-necrotizing acute pancreatitis (NODAP) more often have reduced insulin sensitivity, β-cell compensation, and no significant change in postprandial levels of glucagon and pancreatic polypeptide, suggests a study.
Postprandial hyperglycaemia may increase the risk of incident diabetic retinopathy (DR) in patients with type 2 diabetes (T2D) independently of glycated haemoglobin (HbA1c) status, reports a new study.
Continuous subcutaneous insulin infusion (CSII) appears to be superior to multiple daily injections (MDI) for the management of type 1 or 2 diabetes, leading to lower rates of cardiovascular events and better glycaemic control, according to a new study.
It is never too late to observe a healthy way of life. According to a recent study, adopting a healthy diet and lifestyle at mid-life can still lead to a longer life expectancy free of major chronic diseases.
The sodium glucose co-transporter 2 inhibitor dapagliflozin appears to have therapeutic potential in type 2 diabetes mellitus patients with obstructive sleep apnoea hypopnea syndrome, exerting beneficial effects on apnoea-hypopnea index, hypoxaemia during sleep and daytime sleepiness, as shown in a study.
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.